TAMs respond by modulating cancer cell proliferation, immune regulation, ECM remodeling, tumor cell invasion and metastasis, lymphangiogenesis and vascular angiogenesis by secreting IL-10, VEGF, prokineticin (Bv8), prostaglandin E2, and MMP-9 (75–77). The gene discussed is VEGFA; the disease is neoplasm.